Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecules and Cells

• Publication date

  2006-06-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLCEL.2006.05.022PMID 16793542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular pathogenesis of Fanconi anemia: recent progress.

  2006cited by this paper
• BRCA1 and BRCA2 as ovarian cancer susceptibility genes.

  2005cited by this paper
• The BRCA2-Interacting Protein BCCIP Functions in RAD51 and BRCA2 Focus Formation and Homologous Recombinational Repair

  2005cited by this paper
• Risk factors for pancreatic cancer

  2005cited by this paper
• Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.

  2005cited by this paper
• Targeting the DNA repair defect of BRCA tumours.

  2005cited by this paper
• CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction

  2005cited by this paper
• Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

  2005cited by this paper
• Dynamics of DNA repair suggested by the subcellular localization of Brca1 and Brca2 proteins

  2005cited by this paper
• Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin

  2004cited by this paper
• Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression

  2004cited by this paper
• BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage

  2004cited by this paper
• Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.

  2004cited by this paper
• Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2

  2004cited by this paper
• Molecular views of recombination proteins and their control

  2003cited by this paper
• Breast and ovarian cancer.

  2003cited by this paper
• Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

  2003cited by this paper
• International Congress on Hormonal Steroids and Hormones and Cancer Prostate cancer susceptibility genes: lessons learned and challenges posed

  2003cited by this paper
• Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2.

  2003cited by this paper
• EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

  2003cited by this paper
• The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• BRCA2-dependent and independent formation of RAD51 nuclear foci

  2003cited by this paper
• BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription

  2003cited by this paper
• Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein.

  2003cited by this paper
• Immunoaffinity purification of mammalian protein complexes.

  2003cited by this paper
• Insights into DNA recombination from the structure of a RAD51–BRCA2 complex

  2002cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions

  2002cited by this paper
• BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.

  2002cited by this paper
• Modifiers of risk of hereditary breast and ovarian cancer

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001cited by this paper
• Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

  2001cited by this paper
• BRCA2 is required for homology-directed repair of chromosomal breaks.

  2001cited by this paper
• A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression.

  2001cited by this paper
• Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

  2001cited by this paper
• Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

  2000cited by this paper
• BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.

  1999cited by this paper
• Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

  1999cited by this paper
• Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals

  1999cited by this paper
• Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

  1999cited by this paper
• Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

  1998cited by this paper
• A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.

  1998cited by this paper
• BRCA2 associates with acetyltransferase activity when bound to P/CAF

  1998cited by this paper
• Involvement of Brca2 in DNA repair.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

  1998cited by this paper
• RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 *

  1997cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Transcriptional activation functions in BRCA2

  1997cited by this paper
• BRCA2 germline mutations in male breast cancer cases and breast cancer families

  1996cited by this paper

• Genomic comparisons and the adaptive basis of brain size plasticity and chromosomal instability in the Eurasian common shrew

  2026cites this paper
• The homologous recombination factors BRCA2 and PALB2 interplay with mismatch repair pathways to maintain centromere stability and cell viability

  2025cites this paper
• Single-cell transcriptome analysis reveals regulatory programs of prognosis-associated RNA binding proteins during LIHC development

  2025cites this paper
• Single-cell atlas of the mandarin fish ovary reveals the trajectories of oogenesis and its immune microenvironment development

  2025cites this paper
• Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects

  2025cites this paper
• CXorf67 in malignancies: Deciphering epigenetic landscapes and clinical implications for precision oncology

  2025cites this paper
• Breast Cancer in Women with Moderate and High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes

  2025cites this paper
• Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy

  2025cites this paper
• Skin Cancer Predisposition Genes, Full-Body Skin Examinations, Familial Disclosure, and Genetic Testing Among High-Risk Individuals.

  2025cites this paper
• PALB2 mutations increase oncogenic properties of breast epithelial cells by enhancing JAM3 and PARVB expression.

  2025cites this paper
• Genomic comparisons shed light on the adaptive basis of brain size plasticity and chromosomal instability in the Eurasian common shrew

  2025cites this paper
• PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients

  2025cites this paper
• Deep Learning in Digital Breast Tomosynthesis: Current Status, Challenges, and Future Trends

  2025cites this paper
• TGM2 Regulates Radiosensitivity via POGZ‐Mediated Repair of DNA Double‐Strand Breaks in Cervical Cancer

  2025cites this paper
• PALB2 and 53BP1 govern post-resection homologous recombination DNA repair.

  2025cites this paper
• Cryo-EM visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2

  2025cites this paper
• Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model

  2025cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025cites this paper
• Plant tolerance mechanisms to DNA-damaging UV stress

  2025cites this paper
• Ribo‐Seq Analysis‐Based Elucidation of the Dynamic Translation Landscape of Yak Ovarian Tissues in Different Reproductive Stages

  2025cites this paper
• Exploring the Potential of Homologous Recombination Protein PALB2 in Synthetic Lethal Combinations

  2025cites this paper
• BRCA2 Pre-mRNA Differential 5′ Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 Patients

  2025cites this paper
• Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review

  2025cites this paper
• A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription

  2025cites this paper
• Comprehensive Analysis of BRCA1/2 mutations, "BRCAness" and PARP inhibitors in Melanoma.

  2025cites this paper
• G-quadruplexes as a source of vulnerability in BRCA2-deficient granule cell progenitors and medulloblastoma

  2025cites this paper
• The influence of breast cancer susceptibility genes on radiotherapy efficacy and adverse toxicities

  2025cites this paper
• KEAP1-NRF2 Interaction in Cancer: Competitive Interactors and Their Role in Carcinogenesis

  2025cites this paper
• Mutagenesis of the PALB2 WD40 domain identifies variants defective in interaction with BRCA2 and DNA repair

  2025cites this paper
• WDFY2 promotes MRN complex formation required for homologous recombination-mediated DNA repair.

  2025cites this paper
• Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches

  2025cites this paper
• Understanding the prospective of gene therapy for the treatment of breast cancer

  2025cites this paper
• Advances in the relationship of immune checkpoint inhibitors and DNA damage repair.

  2025cites this paper
• A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition.

  2025cites this paper
• Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer

  2024cites this paper
• Molecular pathways and targeted therapies in head and neck cancers pathogenesis

  2024cites this paper
• Advances in breast cancer research using CRISPR/Cas9 system

  2024cites this paper
• Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China

  2024cites this paper
• BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes

  2024cites this paper
• A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.

  2024cites this paper
• Altered hormone expression induced genetic changes leads to breast cancer

  2024cites this paper
• A RAD18–UBC13–PALB2–RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

  2024cites this paper
• GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer

  2024cites this paper
• An Updated Insight into Phytomolecules and Novel Approaches used in the Management of Breast Cancer.

  2024cites this paper
• A practice changing paper: biallelic inactivation of BRCA2 in Fanconi anaemia

  2024cites this paper
• VGLL3 modulates chemosensitivity through promoting DNA double-strand break repair

  2024cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• Lamin A/C facilitates DNA damage response by modulating ATM signaling and homologous recombination pathways

  2024cites this paper
• Whole-Genome Sequencing Analyses Reveal the Whip-like Tail Formation, Innate Immune Evolution, and DNA Repair Mechanisms of Eupleurogrammus muticus

  2024cites this paper
• Whole exome sequencing of a novel homozygous missense variant in PALB2 gene leading to Fanconi anaemia complementation group

  2024cites this paper
• Fanconi Anemia: Challenges in Diagnosis and Management—A Case Series Report

  2024cites this paper
• Alu–Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of PALB2 Inactivation, Predisposing Individuals to Hereditary Breast–Ovarian Cancer Syndrome

  2024cites this paper
• Harnessing DOT1L and RAP80: unveiling new insights into BRCA1-mediated DNA repair for cancer therapy

  2024cites this paper
• DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair

  2024cites this paper
• Proline variants in the BRCA1 coiled‐coil domain disrupt folding and binding to PALB2

  2024cites this paper
• Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis

  2024cites this paper
• G-quadruplexes are a source of vulnerability in BRCA2 deficient granule cell progenitors and medulloblastoma

  2024cites this paper
• Structure-specific nucleases in genome dynamics and strategies for targeting cancers

  2024cites this paper
• FLIP(C1orf112)-FIGNL1 complex regulates RAD51 chromatin association to promote viability after replication stress

  2024cites this paper
• Graphene Oxide Nanocarriers for Effective Drug Delivery in Breast Cancer Treatment

  2024cites this paper
• Predicting functionally important breast cancer SNPs using pleiotropy, conservation, and protein structure

  2024cites this paper
• DSS1 restrains BRCA2’s engagement with dsDNA for homologous recombination, replication fork protection, and R-loop homeostasis

  2024cites this paper
• Tracking the epidemiological trends of female breast cancer in Saudi Arabia since 1990 and forecasting future statistics using global burden of disease data, time-series analysis

  2024cites this paper
• The strand exchange domain of tumor suppressor PALB2 is intrinsically disordered and promotes oligomerization-dependent DNA compaction

  2023cites this paper
• Medical genetic counseling for patients with identified clinically significant genetic variants associated with hereditary tumor syndromes and their relatives

  2023cites this paper
• Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam

  2023cites this paper
• RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma

  2023cites this paper
• Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients

  2023cites this paper
• The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining.

  2023cites this paper
• A Case of Adolescent Ovarian Sertoli-Leydig Cell Tumor and Literature Review

  2023cites this paper
• Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study

  2023cites this paper
• Local ancestry and selection in admixed Sanjiang cattle

  2023cites this paper
• Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond.

  2023cites this paper
• Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells

  2023cites this paper
• The FLIP-FIGNL1 complex regulates the dissociation of RAD51/DMC1 in homologous recombination and replication fork restart

  2023cites this paper
• Management of PALB2‐associated breast cancer: A literature review and case report

  2023cites this paper
• Evolutionary Origin of Human PALB2 Germline Pathogenic Variants

  2023cites this paper
• Positive and negative regulators of RAD51/DMC1 in homologous recombination and DNA replication.

  2023cites this paper
• Pancreatic Cancer: BRCA Targeted Therapy and Beyond

  2023cites this paper
• Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.

  2023cites this paper
• The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2

  2023cites this paper
• Germline mutations in the PALB2 and CHEK2 genes and hereditary cancer

  2023cites this paper
• RFWD3 promotes ZRANB3 recruitment to regulate the remodeling of stalled replication forks

  2023influential citation
• PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients

  2023cites this paper
• Visualization of direct and diffusion-assisted RAD51 nucleation by full-length human BRCA2 protein

  2023influential citation
• Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis

  2023cites this paper
• Role of detection of mutations in the BRСA1,2, CHEK2, PALB2 genes in diagnosis of oncological diseases and determination of the therapy strategy

  2023cites this paper
• The PALB2 DNA-binding domain is an intrinsically disordered recombinase

  2023cites this paper
• BRCA1 the Versatile Defender: Molecular to Environmental Perspectives

  2023influential citation
• RADIF(C1orf112)-FIGNL1 Complex Regulates RAD51 Chromatin Association to Promote Viability After Replication Stress

  2023cites this paper
• Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer

  2023cites this paper
• Distinct mobility patterns of BRCA2 molecules at DNA damage sites

  2023cites this paper
• New advances in CRISPR/Cas-mediated precise gene-editing techniques

  2023cites this paper
• Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.

  2023cites this paper
• Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population.

  2023cites this paper
• Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer.

  2023cites this paper
• [Matrix stiffening related lncRNA SNHG8 regulates chemosensitivity of ovarian cancer].

  2023cites this paper
• Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations

  2023cites this paper
• Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background

  2023cites this paper
• Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.

  2023cites this paper